Trump Admin Finalizes Higher Medicare Advantage Payment Increase, Boosting Insurer Stocks

The Trump administration finalized a 2.48% payment rate increase for privately run Medicare Advantage plans in 2027, a decision that significantly exceeds its initial proposal and carries substantial implications for health insurer stocks.

The Centers for Medicare & Medicaid Services (CMS) confirmed that average Medicare Advantage payments will increase by 2.48%, totaling more than $13 billion, in 2027.

Key Details

This confirmed increase stands in stark contrast to the Trump administration's earlier proposal in January, which suggested a much more modest 0.09% payment rate hike.

Following the announcement, major health insurer stocks experienced significant gains in after-hours trading. Shares for UnitedHealth and CVS Health each rose by over 9%, while Humana's stock saw an approximate 12% increase.

CMS Administrator Dr. Mehmet Oz commented in a release that "Medicare Advantage and Part D should work for the people who rely on them," emphasizing that "These updates keep coverage affordable and ensure patients get real value from their plans."

Background

The government payment rate is a critical determinant of the monthly premiums and benefits that insurers can offer for Medicare Advantage plans, directly influencing their profitability.

Medicare Advantage plans are privately administered health insurance plans contracted through Medicare. These plans have grown in popularity, with the health policy research firm KFF reporting that over half of all Medicare beneficiaries are now enrolled in them. Beneficiaries are often attracted by additional benefits not provided by traditional Medicare and, in many cases, lower monthly premiums.